Liu W, Li R Y
Department of Dermatology, Peking University First Hospital/National Clinical Research Center for Skin and Immune Diseases/Research Center for Medical Mycology, Peking University/Beijing Key Laboratory of Molecular Diagnosis on Dermatoses/Peking University First Hospital-National Institute for Communicable Disease Control and Prevention Joint Laboratory of Pathogenic Fungi, Beijing 100034, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Dec 10;44(12):1984-1987. doi: 10.3760/cma.j.cn112338-20230701-00410.
The WHO established the first fungal priority pathogens list (FPPL) in October 2022 to focus on and promote further research and policy interventions to strengthen the global response to fungal infections and antifungal resistance. The FPPL and its formulation process provide new significant insights for managing pathogenic fungi and invasive fungal disease (IFD) in China, necessitating the following key actions: Strengthen public health interventions for IFD. Further, it improves the ability of laboratory testing and clinical supervision for IFD and pathogenic fungi. Increase targeted investment and support for innovative research and development in IFD diagnosis, treatment, and prevention.
世界卫生组织于2022年10月制定了首份真菌重点病原体清单（FPPL），以聚焦并推动进一步的研究及政策干预措施，加强全球应对真菌感染和抗真菌耐药性的能力。FPPL及其制定过程为中国管理致病真菌和侵袭性真菌病（IFD）提供了新的重要见解，需要采取以下关键行动：加强针对IFD的公共卫生干预措施。此外，提高对IFD和致病真菌的实验室检测及临床监测能力。增加对IFD诊断、治疗和预防方面创新研发的定向投资与支持。
